Scott Eblen to Apoptosis
This is a "connection" page, showing publications Scott Eblen has written about Apoptosis.
Connection Strength
0.083
-
EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis. 2014 May; 35(5):1100-9.
Score: 0.070
-
Structure-activity relationship (SAR) studies of 3-(2-amino-ethyl)-5-(4-ethoxy-benzylidene)-thiazolidine-2,4-dione: development of potential substrate-specific ERK1/2 inhibitors. Bioorg Med Chem Lett. 2009 Nov 01; 19(21):6042-6.
Score: 0.013